Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease (2021)
- Authors:
- USP affiliated authors: FARSKY, SANDRA HELENA POLISELLI - FCF ; VIEIRA, ANDREA - FM ; SILVA, MARINA DE PAULA - FCF ; ROCHA, GUSTAVO HENRIQUE OLIVEIRA DA - FCF ; BROERING, MILENA FRONZA - FCF ; SANDRI, SILVANA - FCF
- Unidades: FCF; FM
- DOI: 10.3389/fimmu.2021.714138
- Subjects: COLITE; DOENÇA DE CROHN; RECEPTORES; PEPTÍDEOS; BIOMARCADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 12, p. 1-12 art. 714138, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SILVA, Marina de Paula et al. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, v. 12, p. 1-12 art. 714138, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.714138. Acesso em: 27 dez. 2025. -
APA
Silva, M. de P., Rocha, G. H. O. da, Broering, M. F., Queiroz, M. L., Sandri, S., Loiola, R. A., et al. (2021). Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease. Frontiers in Immunology, 12, 1-12 art. 714138. doi:10.3389/fimmu.2021.714138 -
NLM
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fimmu.2021.714138 -
Vancouver
Silva M de P, Rocha GHO da, Broering MF, Queiroz ML, Sandri S, Loiola RA, Oliani SM, Vieira A, Mauro Perretti, Farsky SHP. Formyl peptide receptors and Annexin A1: complementary mechanisms to infliximab in murine experimental colitis and Crohn's disease [Internet]. Frontiers in Immunology. 2021 ; 12 1-12 art. 714138.[citado 2025 dez. 27 ] Available from: https://doi.org/10.3389/fimmu.2021.714138 - Red light-emitting diode treatment improves tissue recovery in DSS-induced colitis in mice
- Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages
- Role of annexin A1 on pioglitazone mediated anti-inflammatory effects on experimental ulcerative colitis
- Cellular and molecular mechanisms of environmental pollutants on hematopoiesis
- Pioglitazone attenuates the effects of peripheral inflammation in a human in vitro blood–brain barrier model
- Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells
- Imunotoxicologia
- Annexin A1/Formyl peptide receptor pathway controls uterine receptivity to the blastocyst
- Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
- Immunotoxic mechanisms of cigarette smoke and heat-not-burn tobacco vapor on Jurkat T cell functions
Informações sobre o DOI: 10.3389/fimmu.2021.714138 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3046018.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
